1. Home
  2. IZM vs MRKR Comparison

IZM vs MRKR Comparison

Compare IZM & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$1.05

Market Cap

12.5M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZM
MRKR
Founded
2011
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
16.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
IZM
MRKR
Price
$1.05
$1.38
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.17
AVG Volume (30 Days)
54.6K
345.5K
Earning Date
10-24-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$187,048,691.00
$4,694,988.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.60
N/A
Revenue Growth
5.12
N/A
52 Week Low
$0.87
$0.81
52 Week High
$2.74
$5.95

Technical Indicators

Market Signals
Indicator
IZM
MRKR
Relative Strength Index (RSI) 48.06 57.89
Support Level $0.89 $1.25
Resistance Level $1.25 $1.48
Average True Range (ATR) 0.10 0.10
MACD 0.05 -0.01
Stochastic Oscillator 59.37 64.71

Price Performance

Historical Comparison
IZM
MRKR

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: